Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | FAAH | O00519 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | CES2 | O00748 | 2/20 | 0.31 |
| ▸ | CES1 | P23141 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7112645 | 0.78 | CES2 (0.36) | ALDH1A1MEN1CYP3A4KMT2ACES2 | |
| SCHEMBL23925665 | 0.78 | CES1 (0.36) | TSHRALDH1A1CES2CES1 | |
| SCHEMBL13715915 | 0.76 | CES2 (0.39) | CES2CES1 | |
| SCHEMBL30184919 | 0.76 | GPR84 (0.40) | ALDH1A1CES2CES1 | |
| SCHEMBL30184911 | 0.74 | CES2 (0.41) | TSHRALDH1A1CES2CES1 | |
| SCHEMBL29393784 | 0.74 | MEN1 (0.37) | TSHRALDH1A1MEN1CYP3A4KMT2A | |
| SCHEMBL30184915 | 0.74 | GPR84 (0.48) | — | |
| SCHEMBL7044114 | 0.72 | ALDH1A1 (0.36) | TSHRALDH1A1MEN1KMT2A | |
| SCHEMBL1834726 | 0.72 | MEN1 (0.40) | TSHRFAAHMEN1CYP3A4KMT2A | |
| SCHEMBL14091098 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4136067-B1 | ODORANTS AND COMPOSITIONS COMPRISING ODORANTS | S H KELKAR AND COMPANY LTD (IN) | 2026-04-15 | — | — | EP | disclosed |
| US-12522780-B2 | Odorants and compositions comprising odorants | S H KELKAR AND COMPANY LIMITED (IN) | 2026-01-13 | — | — | US | disclosed |
| US-20230141482-A1 | ODORANTS AND COMPOSITIONS COMPRISING ODORANTS | S H KELKAR & COMPANY LIMITED (IN) | 2023-05-11 | — | — | US | disclosed |
| EP-4136067-A1 | ODORANTS AND COMPOSITIONS COMPRISING ODORANTS | S H Kelkar and Company Limited (IN) | 2023-02-22 | — | — | EP | disclosed |
| CN-115551829-A | Odorants and compositions comprising odorants | 丝趣科尔卡有限公司 | 2022-12-30 | — | — | CN | disclosed |
| WO-2021209944-A1 | ODORANTS AND COMPOSITIONS COMPRISING ODORANTS | S H KELKAR AND COMPANY LIMITED (IN) | 2021-10-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230141482-A1 | ODORANTS AND COMPOSITIONS COMPRISING ODORANTS | CDY1; CDY1B, ACMSD, ADH5 | TSHR 4551/4885ALDH1A1 14/4885FAAH 56/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.